Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration

BACKGROUND: Sativex(®), a cannabis extract oromucosal spray containing Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD), is currently in phase III trials as an adjunct to opioids for cancer pain treatment, and recently received United Kingdom approval for treatment of spasticity. There are indi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Karschner, Erin L., Darwin, W. David, Goodwin, Robert S., Wright, Stephen, Huestis, Marilyn A.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3717338/
https://ncbi.nlm.nih.gov/pubmed/21078841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/clinchem.2010.152439
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares